Skip to content

URGNUROGEN PHARMA LTD

CUSIP M96088105 · common stock

3 tracked investors held UROGEN PHARMA LTD (URGN) at the end of Q3 2026, worth $19.1M in total. The largest holder was Adar1 Capital Management, with 0.6% of its portfolio.

Holders · Q3 2026
3
New holders
0
Value held
$19.1M
Quarter-end price (est.)
$40.63

Investors holding URGN · Q3 2026

InvestorWeightSharesValueChange
Adar1 Capital Management
ADAR1 Capital Management, LLC
0.64%369,785$15MADD+46.5%
Cathie Wood
ARK Investment Management LLC
0.01%54,250$2.2MREDUCE-46.6%
Polen Capital Management
Polen Capital Management LLC
0.02%46,801$1.9MADD+58.0%

History

QuarterHoldersNewSold outValue heldQuarter-end price (est.)
Q3 2026300$19.1M$40.63
Q2 2026310$14.1M$36.80
Q1 2026200$9.2M$17.98
Q4 2025200$5.8M$23.42